Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: J Adolesc Health. 2015 Mar;56(3):345–351. doi: 10.1016/j.jadohealth.2014.11.009

Table 1.

Demographic and clinical characteristics of 21-year-old human immunodeficiency virus (HIV)–infected youth engaged in care at HIV Research Network sites (N = 647)

Characteristic N (%)
Race
  White 69 (10.7)
  Black 472 (72.9)
  Hispanic 90 (13.9)
  Other/unknown 16 (2.5)
Male gender 404 (62.4)
HIV acquisition risk
  Men who have sex with men 275 (42.5)
  Perinatally HIV infected 96 (14.8)
  Blood transfusion 16 (2.5)
  Heterosexual 232 (35.9)
  Injection drug use 9 (1.4)
  Other/unknown 14 (2.2)
Perinatal/blood HIV-infected youth 112 (17.3)
Nonperinatal HIV-infected youth 535 (82.7)
CD4 category (cells/mm3)
  <50 24 (3.7)
  50–200 58 (9.0)
  >200–349 118 (18.2)
  350–499 181 (28.0)
  ≥500 266 (41.1)
Median CD4 cells/mm3 (interquartile range) 452 (312–625)
HIV viral load category (log10 copies/mL)b
  <2.6 219 (34.8)
  2.6–<4.0 219 (34.8)
  4.0–<4.70 110 (17.5)
  4.70–<5.0 31 (4.9)
  ≥5.0 51 (8.1)
Antiretroviral therapy prescribed 426 (65.8)
Site of HIV care
  Adult site 359 (55.7)
  Pediatric site 286 (44.3)
Insureda 395 (61.3)
Less than four outpatient visits in the year 209 (32.3)
  before the 22nd birthday
a

Insured includes Medicare, Medicaid, dual (Medicare/Medicaid), private insurance, and other insurance, whereas uninsured included Ryan White and uninsured patients.

b

Seventeen patients with no available viral load measurements in year they were 21 years old.